DVL2 and hepatocellular carcinoma: Furthermore, the Dvl2 rescue detected in shASPM HCC cells treated with the autophagy inhibitor 3‐MA confirms that ASPM is necessary to protect Dvl2 from autophagy‐mediated degradation.